Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Mar;22(1):1-8.
doi: 10.1055/s-0032-1331840.

An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors

Nicolas W Shammas  1
Affiliations
Review

An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors

Nicolas W Shammas. Int J Angiol. 2013 Mar.

Abstract

Treatment of the femoropopliteal (FP) artery remains a challenge to the endovascular specialist. Long-term patency is low with a high rate of target lesion revascularization. The true patency rate varies considerably between studies partly because there is a lack of uniform performance criteria and reporting standards in peripheral arterial interventions. Literature review supports three principles that emerge as important components of an optimal strategy in treating the FP artery: (1) improving vessel compliance and subsequently less dissections and bailout stenting, (2) reducing smooth muscle cell proliferation, and (3) protecting outflow vessels from distal embolization. In this overview, we examine current data that support the validity of this strategy.

Keywords: atherectomy; distal embolization; drug-coated balloon; femoropopliteal artery; in-stent restenosis; restenosis; tibial runoff.

PubMed Disclaimer

Conflict of interest statement

Note The author has no commercial, proprietary, or financial interest in any products described in this article. Dr Shammas received related research and educational grants to the Midwest Cardiovascular Research Foundation from eV3 (Covidien), Spectranetics, and CSI. Supported by the Nicolas and Gail Shammas Research Fund at MCRF. Full disclosure at www.mcrfmd.com.

Figures

Fig. 1
Fig. 1
The triad of an optimal peripheral vascular revascularization strategy addresses vessel mechanics and biological responses and optimizes procedural variables to ensure distal vessel protection and operator and patient safety.
See this image and copyright information in PMC

References

    1. Shammas N W. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag. 2007;3(2):229–234. - PMC - PubMed
    1. Anderson P L, Gelijns A, Moskowitz A. et al.Understanding trends in inpatient surgical volume: vascular interventions, 1980–2000. J Vasc Surg. 2004;39(6):1200–1208. - PubMed
    1. Kandarpa K, Becker G J, Hunink M G. et al.Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I. J Vasc Interv Radiol. 2001;12(6):683–695. - PubMed
    1. Laird J R. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther. 2006;13 02:II30–II40. - PubMed
    1. Shammas N W. Optimal strategy in lower extremity peripheral percutaneous interventions: an interventionalist's perspective. Vasc Dis Manage. 2009;6:36–40.